Author: Bella Hayes
New York, New York–(Newsfile Corp. – December 25, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Silvaco Group, Inc. (NASDAQ: SVCO) resulting from allegations that Silvaco may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Silvaco securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To…
New York, New York–(Newsfile Corp. – December 25, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Wolfspeed, Inc. (NYSE: NYSE:) between August 16, 2023 and November 6, 2024, both dates inclusive (the “Class Period”), of the important January 17, 2025 lead plaintiff deadline. SO WHAT: If you purchased Wolfspeed securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Wolfspeed class action, go to https://rosenlegal.com/submit-form/?case_id=30954 or call Phillip Kim, Esq. toll-free at…
Radnor, Pennsylvania–(Newsfile Corp. – December 25, 2024) – The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Zeta Global (NYSE:) Holdings Corp. (“Zeta”) (NYSE: ZETA) on behalf of those who purchased or otherwise acquired Zeta securities between February 27, 2024, and November 13, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 21, 2025. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Zeta losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/zeta-global-holdings-corp?utm_source=PR&utm_medium=link&utm_campaign=zeta&mktm=r You can also contact attorney Jonathan Naji, Esq. by calling…
U.Today – XRP’s recent rally has come to a halt after achieving highs near $3, leaving the market wondering what happens next. Amid the current uncertainty on the crypto market, XRP appears to be consolidating, particularly in its trading pair. Could a breakout against BTC be on the horizon? Over the past few weeks, XRP has been a standout performer, gaining traction amid positive developments in the broader crypto market and positive sentiment around the Ripple (RLUSD) stablecoin launch. XRP rose to highs of $2.90 on Dec. 3, while also reaching highs of $0.00003 in its Bitcoin pairing, a level…
New York, New York–(Newsfile Corp. – December 25, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. (NASDAQ: NASDAQ:) between February 7, 2024 and November 24, 2024, both dates inclusive (the “Class Period”), of the important February 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Cassava securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Cassava class action, go to https://rosenlegal.com/submit-form/?case_id=22374 or call Phillip…
Company announcement “ No. 53 / 2024 Transactions in Zealand Pharma (NASDAQ:) shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, December 25, 2024 “ Zealand Pharma A/S (Zealand) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand Pharma’s shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons and hereby publishes the information on such transactions. Please see the attached file(s). About Zealand Pharma A/S Zealand Pharma A/S…
Company announcement “ No. 52 / 2024 Zealand Pharma (NASDAQ:) major shareholder announcement: The Capital Group Companies, Inc. Copenhagen, Denmark, 25 December 2024 “ Zealand Pharma A/S (Zealand) (: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today reports receipt on 23 December 2024 of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholder: As of 20 December 2024, The Capital Group Companies, Inc. held voting rights corresponding to 6.20% of the total voting rights in Zealand Pharma A/S. The Capital…
Radnor, Pennsylvania–(Newsfile Corp. – December 25, 2024) – The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against PACS Group, Inc. (“PACS”) (NYSE: PACS). The lawsuit is brought on behalf of investors who purchased or otherwise acquired PACS: 1) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with PACS’ April 11, 2024 initial public offering (the “IPO”); and/or 2) securities between April 11, 2024 and November 5, 2024 inclusive (the “Class Period”). The lead plaintiff deadline is…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Customers Bancorp (NYSE:) To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Customers Bancorp between March 1, 2024 and August 8, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York–(Newsfile Corp. – December 25, 2024) – Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims…
This article summarizes the top insider buys and sells for US stocks reported on Tuesday, December 24, 2024. Top Buys: No significant insider purchases were reported for Tuesday, December 24, 2024. Top Sells: No significant insider sales were reported for Tuesday, December 24, 2024. Staying informed about insider trading activity is crucial for investors, as it can provide valuable insights into a company’s prospects. Insiders, such as executives and directors, often have unique knowledge about their company’s performance and future outlook. While insider transactions alone should not be the sole basis for investment decisions, they can serve as one of…